Focus Stocks
Onyx Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Published on Tuesday, 03 January 2012 16:13 Written by TradersHuddle Staff
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2012 at 9:30 a.m. Pacific Time.
Interested parties may access a live webcast of the presentation on our website at:
http://www.onyx-pharm.com/investors/event-calendar
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through Monday, January 23, 2012.
About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx-pharm.com.
SOURCE Onyx Pharmaceuticals, Inc.
Related Articles
- Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
- Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting
- Onyx Pharmaceuticals Reports First Quarter 2012 Financial Results
- Onyx Pharmaceuticals To Present At Upcoming Investor Conferences
- Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
- Onyx Pharmaceuticals to Report First Quarter 2012 Financial Results After Market on May 2, 2012
- Phase 3 Trial of Investigational Compound Regorafenib (BAY 73-4506) in Metastatic Gastrointestinal Stromal Tumors (GIST) Meets Primary Endpoint of Improving Progression-Free Survival
- Onyx Pharmaceuticals Announces Cell Publication Demonstrating Selectivity of Immunoproteasome Inhibitor ONX 0914
- Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma
- Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2011 Financial Results
Related Partner Headlines
- From Earlier: Phase 3 MISSION trial of Nexavar in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival - Benzinga
- Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma - Benzinga
- Onyx Stock Hits New 52-Week High (ONXX) - TheStreet.com
- Notable Options Activity in Onyx Pharmaceuticals, Inc - Benzinga
- Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma - Benzinga
- Notable Call Options Activity in Onyx Pharmaceuticals - Benzinga
- Morgan Stanley Initiates Coverage on Onyx Pharmaceuticals at Underweight, Announces PT of $38 - Benzinga
- Onyx Pharmaceuticals to Consider Sale: Reports - TheStreet.com
- Onyx Rises On Unusually High Volume (ONXX) - TheStreet.com
- Onyx Stock Gaps Up On Today's Open (ONXX) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Stocks to Watch: Hewlett-Packard, Dell - TheStreet.com -
Advantest Corp Stock Upgraded (ATE) - TheStreet.com -
BCB Bancorp Inc. Stock Upgraded (BCBP) - TheStreet.com -
PetMed Express Inc. Stock Downgraded (PETS) - TheStreet.com -
Silicon Laboratories Inc. Stock Downgraded (SLAB) - TheStreet.com -
Hancock Holding Company Stock Downgraded (HBHC) - TheStreet.com -
Learning Tree International Inc. Stock Downgraded (LTRE) - TheStreet.com -
Mobile Mini Inc Stock Downgraded (MINI) - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,502.81 Trade time:4:04PM EDT Value change:▼1.67 (-0.01%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,316.63 Trade time:4:32PM EDT Value change:▲0.64 (0.05%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.08 Trade time:5:16PM EDT Value change:▼8.13 (-0.29%)In The Wires
-
United Resource Holdings Group, Inc. Has Retained Evans Nelson & Company CPAs As Accountant -
Yes Satellite Television Service Provider Says 'Yes' to Radware's ADC and Application Security Solutions -
Alon Holdings Blue Square-Israel Announces Midroog Ltd. Rating of "P-1" for Potential Issuance of Commercial Paper in Israel -
Scientists Warn of Increased Nuclear Radiation Risks -
Black Pepper for Healthy Weight: Nothing to Sneeze At -
Toll Brothers Reports FY 2012 2nd Qtr and 6 Month Results -
QUAN Contacts New Robotics Targets -
Xueda Education Group Announces First Quarter 2012 Financial Results









